×
InspireMD Net Cash Flow 2013-2025 | NSPR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
InspireMD net cash flow from 2013 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
View More
InspireMD Net Cash Flow 2013-2025 | NSPR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
InspireMD net cash flow from 2013 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$184.9B
Intuitive Surgical (ISRG)
$169.9B
IDEXX Laboratories (IDXX)
$51.8B
Edwards Lifesciences (EW)
$47.7B
Alcon (ALC)
$39.2B
IQVIA Holdings (IQV)
$32.1B
DexCom (DXCM)
$29.4B
Mettler-Toledo (MTD)
$26.4B
STERIS (STE)
$24.1B
Waters (WAT)
$17.7B
SONOVA HOLDING (SONVY)
$17.2B
Hologic (HOLX)
$14.8B
Penumbra (PEN)
$10.6B
Globus Medical (GMED)
$8.3B
Sysmex ADR (SSMXY)
$8.1B
Masimo (MASI)
$7.7B
Teleflex (TFX)
$5.6B
Glaukos (GKOS)
$5.5B
TransMedics (TMDX)
$4B
Integer Holdings (ITGR)
$3.8B
LivaNova (LIVN)
$3B
Alphatec Holdings (ATEC)
$2.4B
Veracyte (VCYT)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.2B
Artivion (AORT)
$2.1B
Nihon Kohden (NHNKY)
$1.9B
Elekta AB (EKTAY)
$1.8B
Integra LifeSciences Holdings (IART)
$1.2B
OPKO Health (OPK)
$1.1B
Paragon 28 (FNA)
$1.1B